Lupin's Pithampur Unit Gets Health Canada Clearance
Lupin has said that its Pithampur unit 2 manufacturing facility located in Indore has been cleared by Health Canada after a review. “Following the review, Health Canada has maintained the compliant rating for unit 2 at Pithampur (Indore) and has issued a revised ‘Establishment License’,” Lupin said in a stock market filing.
In November 2017, Lupin had received warning letter from US Food and Drug Administration (FDA) for its manufacturing facilities in Goa and Pithampur, Indore.
2026-10-21
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
PPG launches strategic review: intends to sell North American architectural coatings business with annual revenue of nearly US$1.8 billion
-
Canada's frozen snow crab export trade has performed poorly this year
-
Danning tablets have been successfully exported to Canada and entered the international mainstream drug market
-
Canada sets MRLs for pesticides such as Tiafenacil in some foods
-
NexusBioAg and MustGrow Biologics Announce Exclusive Marketing and Distribution Agreement in Canada
-
Enable the Use of Polysorbate 80 as an Emulsifying Agent
-
Canadian approved industrial grade ethanol for hand sanitizer
-
Rapeseed planting industry suffered unprecedented impact
-
Australia Approves Lab-Grown “Milk Sugar” for Babies—A Breakthrough in Infant Nutrition
-
From Coffee Waste to Superfood Additive: EU Declares Pectin-Rich Arabica Extract Safe for Food Use
Recommend Reading
-
Panama Canal Delays Deeper Draft Cut, but Transit Capacity Is Still Tightening
-
U.S. Strikes Three Iranian Tankers as “Tanker-for-Tanker” Escalation Raises Chemical Shipping Risk
-
Trump Tariff "Boomerang": $2.5 Billion Polysilicon Factory Faces Shutdown Crisis
-
Retinol in Cosmetics: Regulatory Tightening and Market Changes
-
“Clearing the Floor”: DKSH’s Privatization of Its Malaysian Subsidiary Signals a Silent Power Shift in Asia’s Supply Chain
-
The End of Hype: Europe’s Bio-stimulant Industry Faces a Science-First Reckoning by 2030
-
Japan Tightens the Rules—Then Loosens Them: A Surprising Shift in Food Additive Policy
-
Business Society’s Market Outlook for Hydrogen Peroxide on September 7, 2026: Bullish
-
Business Society’s Market Outlook for Lithium Carbonate on September 7, 2026: Volatile
-
Business Society’s Market Outlook for DOP on September 7, 2026: Relatively Resilient with a Slight Bullish Bias